🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to evaluate whether hypofractionated who...
Status
Recruiting
Location
Siriraj Hospital
Start Date
2026-08-03
Trial ID
NCT07709650
Treatments Being Tested
Nelfinavir will increase the efficacy of Cisplatin based chemo- radiation t...
Status
Completed
Location
University of Miami
Start Date
2012-01
Trial ID
NCT01485731
The standard treatment of local advanced cervical cancer is concurrent chem...
Status
Unknown
Location
Xijing hospital, the Fourth Military Medical University
Start Date
2016-02
Trial ID
NCT02703961
This phase II trial compares the effect of hypofractionated radiotherapy (H...
Status
Recruiting
Location
Uganda Cancer Institute
Start Date
2026-03-11
Trial ID
NCT07276360
RATIONALE: Androgens can cause the growth of prostate cancer cells. Androge...
Status
Active Not Recruiting
Location
University of South Alabama Mitchell Cancer Institute
Start Date
2011-07
Trial ID
NCT01368588
This Phase 1, single-site, dose-escalation study is being conducted to dete...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-12
Trial ID
NCT00967928
Treatments Being Tested
The purpose of this study is to evaluate the imaging and gene expression bi...
Status
Active Not Recruiting
Location
University of Wisconsin
Start Date
2023-03-08
Trial ID
NCT05477823
PRO-BOOST-N is a prospective, multicenter, randomized phase II/III clinical...
Status
Recruiting
Location
Affidea Nu-Med, Center of Oncological Diagnostics and Therapy
Start Date
2026-03-19
Trial ID
NCT07426094
This study is a randomized controlled trial designed to compare hypofractio...
Status
Active Not Recruiting
Location
Siriraj Hospital
Start Date
2021-07-15
Trial ID
NCT07605507
The study objective: * To evaluate the response and survival rates after t...
Status
Completed
Location
Chittaranjan National Cancer Institute
Start Date
2007-10
Trial ID
NCT01276730
Treatments Being Tested